Multidimensional mass-spectrometry for early detection of severe sepsis/septic shock in patients with neutropenic fever – a pilot study.
Recruiting
- Conditions
- A41.9Sepsis, unspecified
- Registration Number
- DRKS00000647
- Lead Sponsor
- Institut für Klinische Chemie und LaboratoriumsdiagnostikCenter for Sepsis Control and Care (CSCC)Klinikum Lobeda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Patients with haemato-oncological disease
undergoing chemotherapy with anticipated period of neutropenia which agree to participate in the study
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of diagnostic signatures for early diagnosis of severe sepsis / septic shock
- Secondary Outcome Measures
Name Time Method Assessing the prognostic value of newly identified molecular signatures in patients at high risk of developing severe sepsis/septic shock in comparison to currently available, conventional laboratory parameters and clinical risk factors